Please login to the form below

Not currently logged in
Email:
Password:

teriflunomide

This page shows the latest teriflunomide news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s oral therapy Aubagio approved in the EU for paediatric MS patients

Sanofi’s oral therapy Aubagio approved in the EU for paediatric MS patients

The EC has cleared Aubagio (teriflunomide) as a first-line treatment for paediatric RRMS patients who are ten to 17 years old.

Latest news

More from news
Approximately 6 fully matching, plus 56 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...